遅発毒性の英語

(1)Priority1 の情報で、動物実験において親動物で一般毒性（母体毒性のみではなく、雌雄の親動物にたいする生殖毒性以外の影響以下同じ）が示されない用量で明確な生殖毒性※（精液の測定項目、胎児の偶発的異常の発生率、変異・化骨遅延、胎児／生後児の体重、生後の発生指標のわずかな変化等を除く）が発現すると記載されている物質例文帳に追加

(1) Substance for which it is described that clear reproduction toxicity *(excluding small changes in sperm measurement items, incidence of spontaneous defects in fetus, variant/ossification retardation, fetal/pup body weight, and postnatal developmental assessments) is manifested when taken at a dosage which does not indicate general toxicity (not only maternal toxicity, but also effects except for reproduction toxicity on female and male parental animals; the same shall apply hereinafter) in parental animals in animal experiments in the information of Priority 1. - 経済産業省

(1)動物実験で親動物での一般毒性が発現する用量で明確な生殖毒性（精液の測定項目、胎児の偶発的異常の発生率、変異・化骨遅延、胎児／生後児の体重、生後の発生指標のわずかな変化等を除く）が発現すると記載されている物質例文帳に追加

(1) Substance for which it is described that clear reproduction toxicity (excluding small changes in sperm measurement items, incidence of spontaneous defects in fetus, variant/ossification retardation, fetal/pup body weight, postal developmental assessments) is manifested when taken at a dosage with which general toxicity in parental animals is manifested in animal experiments. - 経済産業省

(2) 動物実験で親動物での一般毒性に関する記述がないが、明確な生殖毒性（精液の測定項目、胎児の偶発的異常の発生率、変異・化骨遅延、胎児／生後児の体重、生後の発生指標のわずかな変化等を除く）が発現すると記載されている物質例文帳に追加

(2) Substance for which it is described that clear reproduction toxicity (excluding small changes in sperm measurement items, incidence of spontaneous defects in fetus, variant/ossification retardation, fetal/pup body weight, postal developmental assessments) is manifested, though descriptions regarding general toxicity in parental animals in animal experiments are not available. - 経済産業省

Priority２の情報で、動物実験において親動物での一般毒性が示されない用量で明確な生殖毒性（精液の測定項目、胎児の偶発的異常の発生率、変異・化骨遅延、胎児／生後児の体重、生後の発生指標のわずかな変化等を除く）が発現すと記載されている物質については、区分 1Ｂにするほど確かな証拠（根拠）はないとし、本指針においては区分２と整理する。例文帳に追加

A substance for which it is described that clear reproduction toxicity (excluding small changes in sperm measurement items, incidence of spontaneous defects in fetus, variant/ossification retardation, fetal/pup body weight, postal developmental assessments) is manifested when taken at a dosage with which general toxicity in parental animals is not manifested in animal experiments, in Priority 2 is determined as having no evidence (ground) reliable enough to be classified as Category 1B, and so is classified as Category 2 in this guideline. - 経済産業省

対数増殖期の藻類細胞を凍結させることを含む、遅延発光による化学物質の毒性評価に用いる藻類細胞の調整方法。例文帳に追加

A method for preparing algal cells that can be used for evaluating the toxicity of a chemical substance by delayed luminescence, wherein the method includes a step of freezing algal cells that is in a logarithmic growth phase. - 特許庁

(3)毒性学的な重要性が低いかまたは最小限な影響（精液の測定項目、胎児の偶発的異常の発生率、変異・化骨遅延、胎児／生後児の体重、生後の発生指標のわずかな変化）のみを誘発する物質も「区分外」とする。例文帳に追加

(3) Substances which are of low toxicological importance or only induce minimum effects (small changes in semen measurement items, incidence of spontaneous defects in fetus, variant/ossification retardation, fetal/pup body weight, postal developmental assessments) are also determined as “Not classified”. - 経済産業省